Loading clinical trials...

Coronary Artery Disease and Its Association With Liver Steatosis Among HIV-Infected Persons | Clinical Trials | Clareo Health

COMPLETED

Coronary Artery Disease and Its Association With Liver Steatosis Among HIV-Infected Persons

NCT00889577•Henry M. Jackson Foundation for the Advancement of Military Medicine

View on ClinicalTrials.gov

Summary

The primary purpose of this study is to evaluate the association between nonalcoholic fatty liver disease (NAFLD) by computed tomography (CT) scan and coronary artery disease (CAD) measured by the calcium (CAC) score among HIV-infected persons.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•HIV patients who participated in our previous Liver Study, conducted at NMCSD, and HIV patients who did not participate in the Liver Study.

Exclusion Criteria

•Women who are pregnant or breastfeeding will be excluded.

Locations (1)

Naval Medical Center San Diego (NMCSD)

San Diego, California, United States

Key Dates

Start Date

December 1, 2008

Primary Completion Date

March 1, 2010

Completion Date

December 1, 2013

Last Updated

March 21, 2023

Enrollment

233

ACTUAL participants

Conditions

HIV InfectionsCoronary Artery DiseaseNon-Alcoholic Fatty Liver Disease

A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1

NCT06694805

HIV Infections

View study

RECRUITINGPHASE4

Tailoring Bleeding Reduction Approaches in Patients Undergoing PCI

NCT05681702

Coronary Artery Disease

View study

RECRUITING

Skeletal Muscle Energetics and Fatiguability in Older Individuals

NCT04142047

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 21, 2023Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Coronary Artery Disease and Its Association With Liver Steatosis Among HIV-Infected Persons

Inclusion Criteria

Exclusion Criteria

A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1

Tailoring Bleeding Reduction Approaches in Patients Undergoing PCI

Skeletal Muscle Energetics and Fatiguability in Older Individuals

"Erectile Function After PCI in MI and Non-MI Patients"

Clinic vs Clinic+Community Outreach HPV Self-Collection to Increase Cervical Screening in Women With HIV

Implementation of Screen, Treat, and Triage for Women Living With HIV in La Romana (iSTAR)